NCT03912974View on ClinicalTrials.gov

Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 4, 2019

Primary Completion Date

November 26, 2020

Study Completion Date

November 26, 2020

Conditions
Healthy
Interventions
DRUG

Escitalopram

see 'arm description'

DRUG

Placebo oral capsule

see 'arm description'

Trial Locations (1)

4056

University Hospital Basel, Clinical Trial Unit, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03912974 - Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects | Biotech Hunter | Biotech Hunter